| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 13.69B | 12.31B | 9.03B | 7.22B | 6.27B | 3.78B |
| Gross Profit | 7.56B | 6.43B | 3.96B | 2.35B | 1.80B | 1.26B |
| EBITDA | 5.87B | 6.14B | 4.31B | 2.92B | 2.37B | 1.56B |
| Net Income | 3.56B | 3.00B | 1.76B | 803.93M | 451.12M | 582.58M |
Balance Sheet | ||||||
| Total Assets | 24.78B | 25.16B | 20.33B | 18.72B | 17.54B | 8.05B |
| Cash, Cash Equivalents and Short-Term Investments | 6.38B | 6.84B | 2.76B | 1.68B | 1.33B | 1.84B |
| Total Debt | 782.18M | 992.56M | 1.89B | 2.48B | 2.23B | 2.97M |
| Total Liabilities | 7.28B | 8.64B | 9.61B | 10.18B | 10.14B | 3.05B |
| Stockholders Equity | 14.24B | 13.42B | 7.92B | 6.15B | 5.19B | 4.62B |
Cash Flow | ||||||
| Free Cash Flow | 3.26B | 3.15B | 1.75B | 461.12M | -827.48M | -587.22M |
| Operating Cash Flow | 5.71B | 5.42B | 3.27B | 2.20B | 1.09B | 755.15M |
| Investing Cash Flow | -2.50B | -2.26B | -958.41M | -1.77B | -3.98B | -277.87M |
| Financing Cash Flow | -1.44B | 956.72M | -1.10B | -228.12M | 2.23B | 55.91M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | HK$82.75B | 17.50 | 27.52% | 0.54% | 48.74% | 56.71% | |
77 Outperform | HK$15.94B | 14.89 | 23.61% | 0.44% | 49.31% | 262.43% | |
70 Outperform | HK$102.80B | 27.53 | 11.01% | 0.16% | 56.67% | 139.25% | |
64 Neutral | HK$30.21B | 6.03 | 33.81% | 1.40% | 10.57% | 112.84% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
55 Neutral | HK$177.87B | 33.06 | ― | 0.93% | ― | ― |